Mind the gap – an inadvertent immunity effect
The COVID pandemic saw in a number of restrictions to protect the health of West Australians, but has...
CPD Verified
How GPs can write a script for exercise
By Dr Casey Whife, Sport & Exercise Physician We’ve told patients to be active since dial-up internet. Australia’s...
New directions in treating airway disease
By Prof Phil Thompson, Respiratory Physician, Nedlands Airway diseases including asthma, chronic bronchitis, bronchiectasis and rhinosinusitis are complex....
Spirometry testing is falling – how GPs can reverse the trend
Declining rates of spirometry testing is posing a problem for COPD diagnosis and management, writes Rael Rivers, acting...
Unusual infectious causes of pulmonary eosinophilia
By Dr Sumit Mehra, Respiratory and Sleep Physician, Dr Alice Culliford, Respiratory Registrar and Dr Mabel Gaastra Medical...
Advancements in robotic assisted lung surgery
By Dr Kriti Sharma, Paediatric Surgical Registrar, and Mr Sanjay Sharma, Cardiothoracic Surgeon Pulmonary lobectomy has been the...
Aspiration risk and weight loss medication
By Dr Peter Baumgartner, Anaesthetist, West Leederville
The list of conditions that could benefit from Glucagon-like Peptide 1 Receptor Agonists (GLP-1 RA) grows.
In June the Therapeutic Goods Administration (TGA) approved Tirzepatide as the first medical treatment for obstructive sleep apnoea (OSA). It has GLP-1 and glucose-dependent insulinotropic peptide activity (GIP). Read More...
Predicting childhood asthma before onset
By Prof Desiree Silva, Director of Research, Joondalup Childhood asthma accounts for 43% of asthma hospitalisations and remains...